Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.
Iglicki M, Busch C, Lanzetta P, Sarao V, Veritti D, Rassu N, Lupidi M, Cebeci Z, Fraser-Bell S, Bernal-Morales C, Sala-Puigdollers A, Zarranz-Ventura J, Gallego-Pinazo R, Maiti A, D'Amico Ricci G, Udaondo P, Loewenstein A, Chhablani J, Zur D. Iglicki M, et al. Among authors: lupidi m. Eye (Lond). 2023 Feb;37(2):280-284. doi: 10.1038/s41433-022-01931-9. Epub 2022 Jan 18. Eye (Lond). 2023. PMID: 35043004 Free PMC article.
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.
Iglicki M, Busch C, Zur D, Okada M, Mariussi M, Chhablani JK, Cebeci Z, Fraser-Bell S, Chaikitmongkol V, Couturier A, Giancipoli E, Lupidi M, Rodríguez-Valdés PJ, Rehak M, Fung AT, Goldstein M, Loewenstein A. Iglicki M, et al. Among authors: lupidi m. Retina. 2019 Jan;39(1):44-51. doi: 10.1097/IAE.0000000000002196. Retina. 2019. PMID: 29697589
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
Busch C, Zur D, Fraser-Bell S, Laíns I, Santos AR, Lupidi M, Cagini C, Gabrielle PH, Couturier A, Mané-Tauty V, Giancipoli E, Ricci GD, Cebeci Z, Rodríguez-Valdés PJ, Chaikitmongkol V, Amphornphruet A, Hindi I, Agrawal K, Chhablani J, Loewenstein A, Iglicki M, Rehak M; International Retina Group. Busch C, et al. Among authors: lupidi m. Acta Diabetol. 2018 Aug;55(8):789-796. doi: 10.1007/s00592-018-1151-x. Epub 2018 May 5. Acta Diabetol. 2018. PMID: 29730822
Wide-field Choroidal Vascularity in Healthy Eyes.
Singh SR, Invernizzi A, Rasheed MA, Cagini C, Goud A, Vupparaboina KK, Cozzi M, Lupidi M, Chhablani J. Singh SR, et al. Among authors: lupidi m. Am J Ophthalmol. 2018 Sep;193:100-105. doi: 10.1016/j.ajo.2018.06.016. Epub 2018 Jun 27. Am J Ophthalmol. 2018. PMID: 29958821
Reply.
Zur D, Iglicki M, Busch C, Lupidi M, Loewenstein A. Zur D, et al. Among authors: lupidi m. Ophthalmology. 2018 Sep;125(9):e61-e62. doi: 10.1016/j.ophtha.2018.03.025. Epub 2018 Aug 21. Ophthalmology. 2018. PMID: 30143101 No abstract available.
Wide-field choroidal thickness profile in healthy eyes.
Rasheed MA, Singh SR, Invernizzi A, Cagini C, Goud A, Sahoo NK, Cozzi M, Lupidi M, Chhablani J. Rasheed MA, et al. Among authors: lupidi m. Sci Rep. 2018 Nov 21;8(1):17166. doi: 10.1038/s41598-018-35640-9. Sci Rep. 2018. PMID: 30464195 Free PMC article.
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter Study.
Busch C, Iglicki M, Okada M, Gabrielle PH, Cohen S, Mariussi M, Amphornphruet A, Cebeci Z, Chaikitmongkol V, Couturier A, Fraser-Bell S, Fung AT, Iannetta D, Radecka L, Laíns I, Rodrigues TM, Lupidi M, Ozimek M, Sala-Puigdollers A, Rehak M, Loewenstein A, Zur D; for the International Retina Group (IRG). Busch C, et al. Among authors: lupidi m. Ophthalmologica. 2019;241(4):211-219. doi: 10.1159/000496942. Epub 2019 Mar 19. Ophthalmologica. 2019. PMID: 30889590
139 results